BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23470844)

  • 21. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of pluripotency by defined factors.
    Okita K; Yamanaka S
    Exp Cell Res; 2010 Oct; 316(16):2565-70. PubMed ID: 20420827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. iPS cell technology-based research for the treatment of diabetic nephropathy.
    Osafune K
    Semin Nephrol; 2012 Sep; 32(5):479-85. PubMed ID: 23062989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induced pluripotent stem cells and promises of neuroregenerative medicine.
    Verma A; Verma N
    Neurol India; 2011; 59(4):555-7. PubMed ID: 21891933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced pluripotent stem cells: current progress and potential for regenerative medicine.
    Amabile G; Meissner A
    Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced pluripotent stem cells.
    Bhowmik S; Li Y
    Chin Med J (Engl); 2011 Jun; 124(12):1897-900. PubMed ID: 21740850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An introduction to induced pluripotent stem cells.
    Hanley J; Rastegarlari G; Nathwani AC
    Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced pluripotent stem cell-derived cardiomyocytes and long QT syndrome: is personalized medicine ready for prime time?
    Priori SG
    Circ Res; 2011 Sep; 109(8):822-4. PubMed ID: 21960720
    [No Abstract]   [Full Text] [Related]  

  • 31. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced pluripotent stem cells for peripheral nerve regeneration.
    Xu W; Cox CS; Li Y
    J Stem Cells; 2011; 6(1):39-49. PubMed ID: 22997844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viable iPSC mice: a step closer to therapeutic applications in humans?
    Betts DH; Kalionis B
    Mol Hum Reprod; 2010 Feb; 16(2):57-62. PubMed ID: 19952032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation.
    Masip M; Veiga A; Izpisúa Belmonte JC; Simón C
    Mol Hum Reprod; 2010 Nov; 16(11):856-68. PubMed ID: 20616150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts.
    Chen M; Sun X; Jiang R; Shen W; Zhong X; Liu B; Qi Y; Huang B; Xiang AP; Ge J
    Cell Biol Int; 2009 Dec; 33(12):1268-73. PubMed ID: 19524692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Commercialization challenges associated with induced pluripotent stem cell-based products.
    Smith D
    Regen Med; 2010 Jul; 5(4):593-603. PubMed ID: 20632862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Make no bones about it: cells could soon be reprogrammed to grow replacement bones?
    de Peppo GM; Marolt D
    Expert Opin Biol Ther; 2014 Jan; 14(1):1-5. PubMed ID: 24053578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.